This recent testimonial in the Boston Globe, about a writer with type 1 diabetes who chose to keep his illness secret from girlfriend for quite some time, has stuck in my head. I can’t seem to stop thinking about the why’s and how’s of concealing your diabetes from people close to you. What a lot of work that would be! And to what end?
The writer, named Joseph Pierandozzi, starts off by stating that “bodily…
Speaking of World Diabetes Day, coming up November 14, I discovered this cool series of YouTube videos that the International Diabetes Federation has been pumping out to catch people’s attention. They’re short and evocative, all supporting the slogan “Understand Diabetes, Get Involved.”
For example, this bit on “how many people have diabetes worldwide?” Do you know the number? I didn’t offhand, either:
Or this one, reminding folks to never let neuropathy sneak up on them…
Read more »
Put your hands up! Who likes to dance?
Good, you’re in.
Even if all you’ve done till now is watch those popular dance shows on TV, you’re still in.
Because Dance Out Diabetes is a new 501c non-profit organization designed to help prevent and manage diabetes through local dance events. Starting out in San Francisco, and soon to expand nationwide, the idea is to invite people with diabetes and at-risk for it, along with their…
I could call today’s guest post a “straggler” from my Summer Reading series, but that might downplay its impact. Good things take time, as noted today by Samantha Katz, who along with a fellow graduate student at Northwestern University, won the the $10K Grand Prize in the 2009 DiabetesMine Design Challenge.
She was subsequently hired by Medtronic as a Global Product Manager for their evolving insulin pump systems (! – and she served as a…
My Spring post on the new injectable type 2 diabetes drug Victoza is in the running for one of the most-commented-ever blog posts here at the ‘Mine. Over 100 people now taking the medication have chimed in.
Victoza, for the unfamiliar, is a new once-daily form of the new-generation GLP-1 drugs that stimulate pancreas cells to release insulin in people with type 2 diabetes. It’s a head-to-head competitor with the injectable drug Byetta, and both…